Clinical trials
Completed Borderline Personality Disorder trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2010 | 1 |
| 2015 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 1 |
| Eli Lilly and Company | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Hospital San Carlos, Madrid | 1 |
| Hospital Vall d'Hebron | 1 |
| Oryzon Genomics S.A. | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Silvia Elisa Hurtado Santiago | 1 |
| University of Barcelona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Borderline Personality Disorder | 9 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Compulsive Personality Disorder | 1 |
| Mental Disorders | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.